1'758 companies found
Metamount Schweiz AG
Sarnen · Since 2011
The core activity of Metamount Schweiz AG is the production of medical cannabis. The company cultivates and refines hemp in a high-tech production line under strict hygiene conditions and produces medical products that are free from chemical additives. The activities include development, research, production, sales and consulting in the field of medical cannabis products.
Metapharma Schweiz AG
Sarnen · Since 2023
The core activity of Metapharma Schweiz AG is the development, manufacture and marketing of pharmaceutical products.
Metaresearch Schweiz AG
Sarnen · Since 2023
The core activity of Metaresearch Schweiz AG is medical research and development of pharmaceutical products for human and veterinary medicine.
metaShape Pharma AG
Riehen · Since 2023
The core activity of MetaShape Pharma AG is the development and marketing of pharmaceutical products and services in the life sciences sector. The company is active in the research and development of medicines and therapies, and also offers services such as market research, asset evaluation and communication management.
Micelle Technology AG
Frauenfeld · Since 2019
Micelle Technology AG develops and offers MyCell Technology®, a micelle-based encapsulation process to increase the bioavailability of fat‑soluble compounds. The technology renders lipophilic ingredients water‑soluble and protects them from gastric degradation, supporting improved oral and topical uptake for nutraceutical, natural-extract and pharmaceutical applications.
Micreos Pharmaceuticals AG
Baar · Since 2021
Micreos Pharmaceuticals AG develops engineered endolysins and recombinant protein therapeutics for dermatological conditions. The company’s lead candidate, MEndoB, targets Staphylococcus aureus in atopic dermatitis and preclinical data indicate safety, target specificity, efficacy including activity against biofilms, and a low propensity for resistance.
MiHKAL GmbH
Allschwil · Since 2021
The core activity of MiHKAL GmbH is the research and development of new medicines, particularly antidepressants, through the synthesis and development of small molecules and psychoactive compounds.
miVital AG
St. Gallen · Since 2006
The core activity of miVital AG is the development and manufacture of micellized active ingredients for the pharmaceutical industry. Through a patented process, poorly soluble substances are packaged with a water-soluble coating to increase the bioavailability of fat-soluble substances. The company offers individual development orders and delivery of basic solubilizers to optimize customer benefits for specific target segments.
Moderna Switzerland GmbH
Basel · Since 2020
The core activity of Moderna is the development and application of mRNA technology for the treatment and prevention of diseases. The company focuses on researching and developing medicines and therapies based on the mRNA platform to combat various diseases, including rare diseases and individually tailored therapies.
Mogon Pharmaceuticals Sagl
Melide · Since 2014
The core activity of Mogon Pharmaceuticals Sagl consists in the development and provision of solutions for drug delivery, particularly through the development of technology platforms for controlled drug delivery, including immediate and modified release systems for oral applications.
MOHE BioTech (Suisse) SA
Zug · Since 2023
The core activity of Mohe BioTech is the development and provision of products and services in the field of biotechnology, which are intended for both professional and personal use.
M. Opitz & Co. AG
St. Gallen · Since 1965
The core activity of M. Opitz & Co. AG is the development, manufacture and marketing of cosmetic products. The company offers contract manufacturing, quality assurance, packaging and research & development for cosmetic products, with a strong focus on sustainability and environmental protection.
Mosanna Therapeutics AG
Basel · Since 2022
The core activity of Mosanna Therapeutics AG is the development of therapeutics for the treatment of metabolic obstructive sleep apnea syndrome (OSA).
MPC Therapeutics SA
Geneva · Since 2018
The core activity of MPC Therapeutics SA is the development of innovative products that improve the fitness, persistence and performance of cells, particularly T cells, mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs). This is achieved through modulation of mitochondrial function, specifically by targeted influence on the mitochondrial pyruvate carrier (MPC) and other key metabolic pathways. The company develops small molecules that modulate mitochondrial function to enhance the therapeutic efficacy of cell therapies.
MSD BD-4 GmbH
Lucerne · Since 2024
msd GmbH
Bern · Since 2003
msd GmbH is a research-focused biopharmaceutical company that discovers and develops medicines and vaccines. Its main areas include oncology, vaccines, infectious diseases and cardiometabolic disorders, and the company conducts clinical research and trials.
MSD Innovation & Development GmbH
Zürich · Since 2019
MSD Innovation & Development GmbH is a research-focused company concentrating on the discovery and development of medicines and vaccines. It conducts scientific research and supports clinical trials, and provides information and services for healthcare professionals and patients.
MSD International Business GmbH
Lucerne · Since 2018
MSD International Business GmbH is a pharmaceutical company that conducts scientific research, discovers and develops medicines and vaccines, and undertakes clinical trials. It also provides information portals for patients and healthcare professionals and carries out activities related to supply management and animal health.
MSD International GmbH
Lucerne · Since 2010
MSD International GmbH focuses on scientific research and on the development and supply of medicines and vaccines, and conducts clinical research.
Mundipharma AG
Basel · Since 1972
How the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register